| FFIV |
Report |
Q3 FY26 revenue |
BEAT |
pred ~$846M vs. cons $832.1M |
MEDIUM |
| FFIV |
Report |
Q3 FY26 non-GAAP EPS |
BEAT |
pred ~$4.11 vs. cons $3.98 |
MEDIUM |
| FFIV |
Report |
Q3 FY26 product revenue |
BEAT |
pred ~$440M vs. cons $429.8M |
MEDIUM |
| FFIV |
Guide |
Q4 FY26 revenue |
LOWER |
guide ~$860M vs. cons $864M (Q4 FY26) |
MEDIUM |
| FFIV |
Guide |
Q4 FY26 non-GAAP EPS |
LOWER |
guide ~$4.08 vs. cons $4.16 (Q4 FY26) |
MEDIUM |
| FFIV |
Guide |
FY26 revenue |
BETTER |
guide ~$3.34B vs. cons $3.33B (FY26) |
MEDIUM |
| FFIV |
Guide |
FY26 non-GAAP EPS |
BETTER |
guide ~$16.54 vs. cons $16.49 (FY26) |
LOW |
| FFIV |
Return |
Day-1 residual (stock − beta × S&P 500) |
-6.5% |
— |
MEDIUM |
| FFIV |
Return |
5-day cumulative residual |
-8.5% (FOLLOW-THROUGH) |
Q3 beats are outweighed by Q4 EPS guide ~$4.08 vs. cons $4.16 as memory-cost pressure lowers out-period margin and estimate revisions despite a modest FY26 raise. |
MEDIUM |